Operating Lease, Right-of-Use Asset of Mereo BioPharma Group plc from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mereo BioPharma Group plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Mereo BioPharma Group plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $378,000, a 58% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Mereo BioPharma Group plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $378,000 -$531,000 -58% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $522,000 -$463,000 -47% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $622,000 -$487,000 -44% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $727,000 -$518,000 -42% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $909,000 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $985,000 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,109,000 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $1,245,000 -$420,000 -25% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q4 2022 $1,665,000 31 Dec 2022 10-K 27 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.